Oncology drug reimbursement climate in Canada
Canada remains a prime destination for the expansion of both early and late phase oncology clinical trials due the fact…
FAQs – Oncology Clinical Research In Canada
At every industry event, from ASCO to DIA to ASH, I meet with senior executives from oncology drug developers looking to mitigate…